Movement Disorders  >>  Nenad (lisuride transdermal)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nenad (lisuride transdermal)
NCT00367822 / 2005-003549-16: Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)

Completed
3
300
Europe
Lisuride, Ropinirole, Placebo
Axxonis Pharma AG
Restless Legs Syndrome
 
 
2006-003732-30: Transdermal Use of Lisuride in Early Parkinson´s Disease: A double blind, randomized, Placebo and Pramipexole controlled study to evaluate the efficacy and safety of Lisuride TTS

 
3
140
Europe
Lisuride TTS 10cm², Lisuride TTS 20cm², Sifrol 0,088, Sifrol 0,18, Sifrol 0,35, Sifrol 0,7, Sifrol 0,088, Sifrol 0,18, Sifrol 0,35, Sifrol 0,7
Axxonis Pharma AG, NeuroBiotec Pharma AG, NEUROBIOTEC GMBH
Early Parkinson\'s Disease
 
12/09

Download Options